Journals / Retina-Vitreus / 2014 / Cilt: 22 - Sayı: 4

Prognostic significance of optical coherence tomographic findings in retinal vein occlusions

Retinal ven tıkanıklıklarında optik koherens tomografi bulgularının prognostik önemi

Pages
283–288
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: With respect of initial anatomical changes that could be detected via OCT, such as retinal cystic lesions and subretinal fluid formation, as well as changes in final visual acuity and macular thickness scores were not statistically dif- ferent in both CRVO and BRVO cases.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the prognostic value of common optical coherence tomographic (OCT) findings in retinal vein occlusions.
📊
Key Findings & Data:Materials and Methods: Seventy-six eyes of 76 patients who applied our retina department between February 2010-October 2013, with the diagnosis of nonischemic central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) that developed within 3 months, were enrolled in the study.
💡
Conclusion & Impact:Conclusion: With respect of initial anatomical changes that could be detected via OCT, such as retinal cystic lesions and subretinal fluid formation, as well as changes in final visual acuity and macular thickness scores were not statistically dif- ferent in both CRVO and BRVO cases.
🔬Design:Research Article
📍Scope:2010 Verileri
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the prognostic value of common optical coherence tomographic (OCT) findings in retinal vein occlusions. Materials and Methods: Seventy-six eyes of 76 patients who applied our retina department between February 2010-October 2013, with the diagnosis of nonischemic central retinal vein occlusion (CRVO) or branch retinal vein occlusion (BRVO) that developed within 3 months, were enrolled in the study. Study population was classified into 3 subgroups with respect of OCT findings as follows: Cases with multiple retinal cystic lesions that at least one of which was greater than 500 microns (Group 1); cases with diffuse retinal edema that was consisted of multiple cystic lesions that were smaller than 250 microns (Group 2); and cases with intense subretinal fluid (Group 3). Results: In 32 cases (42.1%), CRVO was diagnosis, whereas BRVO was found in 44 cases (57.9%). Mean follow-up was found as 16.2±6.5 months (6-42 months), and 19.8±8.6 months (6-45 months) in patients, respectively. At the last follow-up visit, mean 14.2 ETDRS letters of gain (p:0.001) and mean -274 microns of CMT decrease (p:0.001) were found in patient with CRVO, additively, such scores were found as 16.2 letters (p:0.001) and -312 microns (p:0.001) in cases with BRVO. However no statistical significant difference was found among OCT-based classified subgroups in eyes with CRVO and BRVO (p>0.05). Conclusion: With respect of initial anatomical changes that could be detected via OCT, such as retinal cystic lesions and subretinal fluid formation, as well as changes in final visual acuity and macular thickness scores were not statistically dif- ferent in both CRVO and BRVO cases.

Özet

Amaç: Retinal ven tıkanıklıklarında sıklıkla saptanan optik kohorens tomografi (OKT) bulgularının prognostik değerinin araştırılması. Gereç ve Yöntem: Şubat 2010-Ekim 2013 tarihleri arasında hastanemiz Retina birimine başvuran ve semptomları son üç ay içinde gelişen; non-iskemik santral retinal ven tıkanıklığı (SRVO) veya retinal ven dal tıkanıklığı (BRVO) tanısı alan, 76 hastanın 76 gözü çalışmaya dahil edildi. Hastalar OKT bulgularına göre; en az bir tanesi >500 μm olmak üzere multiple kistik yapıların eşlik ettiği olgular (KMÖ), (Grup 1), 0.05). Sonuç: Santral retinal ven tıkanıklığı ve BRVO’da OKT bulgularına ait tedavi öncesi değişik miktarlarda saptanan retina içi kistik ve retina altı sıvısı gibi anatomik değişiklikler ile görme keskinliği ve maküla kalınlığı açısından sonuç kazanımlar arasında belirgin fark saptanmamıştır.

🔖

Cite This Article

KAYA, M., TAKEŞ, Ö., ÖZTÜRK, A. T., ÖNER, F. H. (2014). Prognostic significance of optical coherence tomographic findings in retinal vein occlusions. Retina-Vitreus, Cilt: 22 - Sayı: 4, 283–288. https://ajindex.com/articles/308134

References (1)

  1. Rogers S, McIntosh RL, Cheung N, et al. International Eye Disease Consortium: The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology 2010;117: 313-19. 2.The Central Vein Occlusion Study Group. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-95. 3.Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Oph- thalmol Soc 2000;98:133-41. 4.Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol 1994;42:109-32. 5.Jonas J, Paques M, Monés J, et al. Retinal vein occlusions. Dev Ophthalmol 2010;47:111-35. 6.Branch Vein Occlusion Study Group. Argon laser photocoagu- lation for macular edema in branch vein occlusion. Am J Oph- thalmol 1984;98:271-82. 7.London NJ, Brown G. Update and review of central retinal vein occlusion. Curr Opin Ophthalmol 2011;22:159-65. 8.Bhisitkul RB, Campochiaro PA, Shapiro H, et al. Predictive value in retinal vein occlusions of early versus late or incom- plete ranibizumab response defined by optical coherence to- mography. Ophthalmology 2013;120:1057-63. 9.Murakami T, Tsujikawa A, Miyamoto K, et al. Relationship between perifoveal capillaries and pathomorphology in macu- lar oedema associated with branch retinal vein occlusion. Eye 2012;26:771-80. 10. Kang HM, Chung EJ, Kim YM, et al. Spectral-domain optical coherence tomography (SD-OCT) patterns and response to in- travitreal bevacizumab therapy in macular edema associated with branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2013;251:501-8. 11. Noma H, Funatsu H, Mimura T, et al. Visual function and se- rous retinal detachment in patients with branch retinal vein occlusion and macular edema: a case series. BMC Ophthalmol 2011;11:29. 12. Campochiaro PA, Heier JS, Feiner L, et al. BRAVO Investiga- tors. Ranibizumab for macular edema following branch reti- nal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1102-12. 13. Brown DM, Campochiaro PA, Singh RP, et al. CRUISE Inves- tigators. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology 2010;117:1124-33. 14. Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for mac- ular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial. Ophthalmology 2012;119:802-9.